Claude Code flaws allow remote code execution and API key theft via untrusted repositories; three bugs fixed across 2025–2026 releases.
Bitcoin Miner Canaan Acquires Cipher’s Stake in Texas Mining Projects, Expands AI and Power Strategy
Canaan (CAN) acquired Cipher Mining’s 49% stake in three West Texas mining projects for $39.75 million in shares, giving Cipher a significant equity stake in Canaan.
GameSpot may get a commission from retail offers. Code Vein 2 features a variety of hot springs your character can find and bathe in throughout your adventure. It's a good idea to do this if you want ...
Megan Molteni reports on discoveries from the frontiers of genomic medicine, neuroscience, and reproductive tech. She joined STAT in 2021 after covering health and science at WIRED. You can reach ...
Advent of Code is a globally celebrated annual programming challenge that takes place from December 1st through December 25th. Each day during this period, a brand-new puzzle is unveiled, designed to ...
Curious how the Caesar Cipher works? This Python tutorial breaks it down in a simple, beginner-friendly way. Learn how to encode and decode messages using one of the oldest and most famous encryption ...
Vibe coding works best in tiny steps, not big specs. Persistent AI documentation eliminates re-ramp time. Git, backups, and exports are critical safety nets. This is not my first vibe coding rodeo. I ...
PythoC lets you use Python as a C code generator, but with more features and flexibility than Cython provides. Here’s a first look at the new C code generator for Python. Python and C share more than ...
xAI Grok 4.20 created a 47% return in the Nasdaq and outperformed all others in the Alpha Arena competition. 32 instances of various LLMs (including multiple variants of the same model under different ...
Python has become one of the most popular programming languages out there, particularly for beginners and those new to the hacker/maker world. Unfortunately, while it’s easy to get something up and ...
Cipher Pharmaceuticals is a profitable, growing Canadian drug company focused on acquiring and marketing niche pharmaceuticals, not developing new drugs. The recent acquisition of Natroba, a head lice ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results